Dr. Gulati is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1275 York Ave
New York, NY 10065Phone+1 212-639-2117
Summary
- Dr. Amitabh Gulati is an anesthesiologist in New York, NY and is affiliated with Memorial Sloan-Kettering Cancer Center. He received his medical degree from Baylor College of Medicine and has been in practice 15 years. He specializes in pain medicine and is experienced in ultrasound-guided injections and cancer pain medicine.
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Pain Medicine, 2006 - 2007
- Emory University School of MedicineResidency, Anesthesiology, 2003 - 2006
- Baylor College of MedicineInternship, Internal Medicine, 2002 - 2003
- Baylor College of MedicineClass of 2002
Certifications & Licensure
- NJ State Medical License 2021 - 2025
- NY State Medical License 2006 - 2025
- GA State Medical License 2004 - 2009
- American Board of Anesthesiology Anesthesiology
- American Board of Anesthesiology Pain Medicine
Publications & Presentations
PubMed
- Outcomes of Palliative Hemipelvectomy in Comprehensive Cancer Center Patients with Metastatic Cancer: Retrospective Study.Roni Rosen, Amitabh Gulati, Christan Bartsch, Erin P Santos, Garrett Nash
Journal of the American College of Surgeons. 2024-12-12 - Peripheral Nerve Stimulation for Pain Management: A Survey of Clinical Practice Patterns.Jay Karri, Eellan Sivanesan, Amitabh Gulati, Vinita Singh, Soun Sheen
Neuromodulation. 2024-10-11 - The Polyanalgesic Consensus Conference (PACC)®: Updates on Clinical Pharmacology and Comorbidity Management in Intrathecal Drug Delivery for Cancer Pain.Timothy R Deer, Salim M Hayek, Jay S Grider, Jason E Pope, Shane E Brogan
Neuromodulation. 2024-09-20
Press Mentions
- Hinge Health Launches Enso 3: A New FDA-Cleared Device for Chronic PainSeptember 10th, 2024
- Hinge Health Acquires Medical Device Company Enso to Expand Pain Management TechnologyMarch 9th, 2021
- Radiotherapy-Specific Chronic Pain Syndromes in the Cancer Population: An Evidence-Based Narrative ReviewFebruary 11th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: